6-Bromo-4-chloro-7-methoxy-2-methylquinazoline

Catalog No. :
ACBHGV062
CAS No. :
2230840-18-1
Molecular Formula :
C10H8BrClN2O
Molecular Weight :
287.54

IUPAC Name:6-bromo-4-chloro-7-methoxy-2-methylquinazoline

6-Bromo-4-chloro-7-methoxy-2-methylquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$74.00Login to see priceIn stockIn stock
1g98%$193.00Login to see priceIn stockInquiry
5g98%$962.00Login to see priceIn stockInquiry
25g98%$4325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-4-chloro-7-methoxy-2-methylquinazoline
IUPAC Name6-bromo-4-chloro-7-methoxy-2-methylquinazoline
MDL No.MFCD32264851
Molecular FormulaC10H8BrClN2O
Molecular Weight287.54
SMILESCC1=NC(Cl)=C2C=C(Br)C(OC)=CC2=N1
InChI KeyIUMTYOIHFSMPLQ-UHFFFAOYSA-N
SynonymQuinazoline, 6-bromo-4-chloro-7-methoxy-2-methyl-;6-?bromo-?4-?chloro-?7-?methoxy-?2-?methyl-quinazoline
CAS No.2230840-18-1
PubChem CID146013200

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBHGV062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBHGV062 route product structure diagram
    ACBHGV0622230840-18-1 In Stock
Inquiry

2. ACBHGV062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBHGV062 route product structure diagram
    ACBHGV0622230840-18-1 In Stock
Inquiry

Comments (0)